Showing results (2101-2110 of 2,151) with videos related to

Sort By:
Pageof 216
Journal of the American College of Cardiology|April 8, 2022
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic StrokeJuliane Schweizer, Markus Arnold, Inke R König, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Diagnostic Performance of PSMA PET/MRI in Characterizing LI-RADS 3 Observations in Patients with CirrhosisOnofrio Antonio Catalano, Irun Bhan, Luigi Asmundo, et al.
The Science of the Total Environment|June 5, 2021
Climate sensitivity and drought seasonality determine post-drought growth recovery of Quercus petraea and Quercus robur in EuropeArun K Bose, Daniel Scherrer, J Julio Camarero, et al.
The Lancet. Global Health|June 18, 2021
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort studyVictor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, et al.
The Lancet. Global Health|September 30, 2022
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trialVictor Kande Betu Kumesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, et al.
Nature|September 12, 2018
Tracing HIV-1 strains that imprint broadly neutralizing antibody responsesRoger D Kouyos, Peter Rusert, Claus Kadelka, et al.
European Heart Journal. Cardiovascular Imaging|January 20, 2024
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic studyJuan Cotella, Michael Randazzo, Mathew S Maurer, et al.
Lancet (London, England)|November 9, 2017
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trialVictor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, et al.
Pageof 216